Remove Big Data Remove DNA Remove Engineer Remove Life Science
article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.

article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bioinformatics Jobs: How to Succeed in This Competitive Space

XTalks

The minimum requirement to become a professional in the bioinformatics field includes having a bachelor’s and master’s degree in bioinformatics, computer engineering, computational biology, computer science, or related field. Bioinformatics Engineer. How to Become a Bioinformatics Engineer. Job Description.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used an AI target discovery engine to analyse transcriptomic data to identify dual targets for cancer and ageing 5.

article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

The mysteries of cancer are starting to yield to the range of advanced therapies available and cell therapies – especially engineered cell therapies – are at the leading edge of that progress.” – Carlo Russo, CEO of Genenta.? . “In Chris Nowers, CEO, ONK Therapeutics. . “ But challenges remain.